Peripheral Vascular Devices – Market Insights – Europe

The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration of endovascular techniques, especially for the revascularization of the iliac and lower-limb arteries. Nevertheless, market growth will be limited to some extent by price competition, unfavorable reimbursement, and unwillingness to some clinicians to adopt new technologies.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Europe from 2019 through 2034.

Uptake of premium-priced devices and emerging products will drive growth in the market.

Which markets will show the highest growth rates in Europe?

To what degree will DES and DCBs be adopted in Europe over the forecast period?

What is the future outlook for the adoption of covered SX and BX stents?

How readily have IVL procedures been adopted for PV indications? Are new devices expected to enter the market?

To what extent will recently launched BRS be adopted?

What impact will these trends have on the competitive landscape?

The generation of clinical evidence is key to driving adoption of new technologies.

Which devices have shown the most positive outcomes?

Which are the most relevant clinical trials that are currently ongoing?

What impact have head-to-head trials had on physicians’ device preferences?

Procedure volume growth will be driven by greater adoption of interventional endovascular techniques for infrapop (BTK) artery revascularization.

How will product innovation contribute to procedure volume growth?

Which devices are likely to see the greatest uptake?

How does this trend affect the PV device market?

Merger and acquisition activities or partnerships involving key competitors may lead to shifts in market shares going forward.

Which acquisitions have occurred, and how will these acquisitions impact competitor performance in the future?

How are competitors leveraging product portfolio acquisitions to expand their product offerings?